Valneva, a French company, is producing a COVID-19 vaccine that it hopes will offer much better protection against most variants of the coronavirus.
If it does, it would greatly reduce, if not eliminate, the need for booster shots.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
